Molecular docking and structure-based drug design strategies.

Ferreira LG, Dos Santos RN, Oliva G, Andricopulo AD. · 2015

Read Molecular docking and structure-based drug design strategies. by Ferreira LG, Dos Santos RN, Oliva G, Andricopulo AD. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6332083.txt.

Description

Ferreira and co-authors review molecular docking in structure-based drug design. Their review appeared in Molecules in 2015. Docking software predicts how a drug fits its target. It estimates how strongly the two bind. Drug hunters use it to screen compounds fast. Many algorithms now compete for that job.

Each method has strengths and blind spots. The review weighs those trade-offs in detail. It shows how docking pairs with lab experiments. Structure-based and ligand-based methods can also merge. That mix has produced promising drug leads. Knowing each tool's limits helps teams plan better. The authors aim to guide medicinal chemists in choosing. The goal is docking results that hold up in practice.

Catalog record

CREATORFerreira LG, Dos Santos RN, Oliva G, Andricopulo AD.
YEAR2015
COLLECTIONPAPERS
FORMATTXT
FILE SIZE101 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6332083

Browse the full library · About the Tower of Babel